CRKN · As filed with the SEC
Crown Electrokinetics cash flow statement, by quarter
The statement as Crown Electrokinetics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Cash Flows · USD thousands
| USD thousands | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024† 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 | Q4 2023† 3 months ended Dec 31, 2023 | Q3 2023† 3 months ended Sep 30, 2023 | Q2 2023† 3 months ended Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net loss | — | — | — | (5,029)† | (4,612) | — | — | (14,519)† |
| Net income (loss) | (9,684) | (10,441)† | — | — | — | (9,306)† | (2,859)† | (14,519)† |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Stock-based compensation related to issuance of warrants in exchange for services | 1,627 | — | — | — | — | — | — | — |
| Provision for credit loss expense | 295 | — | — | — | — | — | — | — |
| Stock-based compensation and employee inducement award | 487 | 673† | 2,153† | 2,150† | 274 | 268† | 133† | 132† |
| Depreciation and amortization | — | — | — | — | — | — | — | 190† |
| Change in fair value of warrant liability | — | — | — | — | — | — | — | (2,130)† |
| Depreciation and amortization | 473 | 421† | 408† | 74† | 212 | 191† | 170† | 190† |
| Loss on extinguishment of warrant liability | — | 0† | 0† | 0† | 0 | 0† | 0† | 0† |
| Change in fair value of warrant liability | 0 | 0† | 0† | (23)† | 23 | (34)† | (2,688)† | (2,130)† |
| Change in fair value of derivative liability | — | 0† | — | — | — | 0† | — | — |
| Gain on issuance of convertible note | — | 0† | — | — | 0 | 0† | — | — |
| Amortization of debt discount | — | — | — | — | 0 | — | — | — |
| Loss on extinguishment of debt | — | 0† | 0† | — | — | 0† | 0† | 1,841† |
| Change in fair value of notes | — | 0† | 0† | 0† | 0 | 0† | 40† | 6,883† |
| Amortization of deferred debt issuance costs | — | — | — | — | — | — | — | 4,113† |
| Amortization of deferred issuance costs | 0 | 223† | 69† | 70† | 944 | 2,541† | 2,751† | 2,414† |
| Amortization of right-of-use assets | 194 | 239† | 158† | 215† | 168 | 287† | 96† | 912† |
| Loss on disposal of equipment | — | 0† | 0† | — | — | (236)† | 145† | — |
| Other expenses | — | — | — | 0† | 0 | 161† | (808)† | 69† |
| Other non-cash expenses | — | (40)† | — | — | — | 163† | — | — |
| Changes in operating assets and liabilities: | ||||||||
| Prepaid and other assets | 94 | 108† | (30)† | 225† | (111) | (75)† | 150† | 147† |
| Accounts and retention receivables | 121 | (489)† | (1,518)† | (1,999)† | (693) | (83)† | 0† | 0† |
| Contract assets | (642) | (1,803)† | 989† | (1,244)† | — | 0† | 0† | — |
| Note receivables | — | — | — | 365† | (576) | — | — | 0† |
| Contract liabilities | 0 | — | (1,020)† | 0† | 1,260 | — | 0† | 0† |
| Accounts payable | — | — | 1,582† | (82)† | 797 | 521† | (154)† | 761† |
| Nonrelated Party | (423) | — | — | — | — | — | — | — |
| Related Party | (1,423) | — | — | — | — | — | — | — |
| Accrued expenses and other current liabilities | (1,953) | 2,728† | 19† | (104)† | (228) | 1,015† | 167† | 178† |
| Lease liability | — | — | — | — | — | — | — | (967)† |
| Lease liabilities | (180) | (167)† | (144)† | (203)† | (171) | (664)† | (99)† | (967)† |
| Warranty customer liability | — | — | — | — | 36 | — | — | — |
| Net cash used in operating activities | (11,014) | (6,419)† | (2,909)† | (6,176)† | (2,677) | (4,351)† | (3,421)† | (3,660)† |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Cash paid for acquisition of Amerigen 7 | — | — | — | — | — | — | — | 1† |
| Cash paid for acquisition of Amerigen 7 | — | — | — | — | — | 0† | — | — |
| Cash paid for acquisition of Amerigen 7 | — | 0† | 0† | 0† | 0 | 0† | (1)† | 1† |
| Purchase of equipment | — | — | — | 7† | (63) | — | — | (272)† |
| Purchases of property and equipment | (1,659) | (4,022)† | — | — | — | (1,089)† | — | — |
| Advances on note receivable | — | 0† | — | — | — | 0† | — | — |
| Repayments of note receivable | 2 | 96† | — | — | — | 0† | — | — |
| Net cash used in investing activities | (1,657) | (3,926)† | (2,225)† | 7† | (63) | (1,089)† | (378)† | (271)† |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Proceeds from the exercise of warrants | — | 0† | 0† | 0† | 0 | 0† | 1† | (1)† |
| Proceeds from the issuance of common stock and warrants, net of fees | — | — | — | — | 0 | — | — | — |
| Proceeds from the issuance of common stock / at-the-market offering, net of issuance costs | 21,476 | 19,503† | 1,183† | 0† | 588 | 4,441† | 2,382† | 0† |
| Proceeds from the issuance of common stock / At-the-market offering | — | — | — | — | — | 4,441† | 1,759† | 0† |
| Proceeds from the issuance of notes in connection with line-of-credit | — | 0† | 0† | 0† | 0 | 0† | 0† | 350† |
| Offering costs for the issuance of common stock / At-the-market offering | — | — | — | — | — | 0† | (79)† | 0† |
| Proceeds from issuance of senior secured convertible notes and common stock warrants | — | — | — | — | — | — | — | (1)† |
| Proceeds from issuance of Series F-1 preferred stock | — | 0† | 0† | — | — | 0† | 0† | — |
| Proceeds from issuance of Series F-2 preferred stock | — | — | — | — | — | — | — | (222)† |
| Proceeds from issuance of Series F-2 preferred stock | — | 0† | 0† | — | — | 0† | 0† | — |
| Proceeds from issuance of Senior Secured Notes, net of fees paid | — | 0† | 0† | — | — | 0† | 0† | — |
| Borrowing of notes payable | — | — | — | 1,164† | 0 | 0† | 1,357† | 1,380† |
| Repayments of notes payable | (54) | (59)† | 606† | (638)† | (8) | 0† | (351)† | (1,983)† |
| Proceeds from lines-of-credit | — | 0† | — | — | — | 0† | — | — |
| Repayments of lines-of-credit | — | 0† | — | — | — | 0† | — | — |
| Proceeds from the issuance of common stock in connection with equity line-of-credit, net of issuance costs | 0 | 1,513† | 3,606† | 9,343† | 1,391 | 0† | 4,489† | 0† |
| Net cash provided by financing activities | 21,422 | 20,957† | 4,231† | 9,869† | 1,971 | 4,441† | 5,819† | 1,829† |
| Net increase / decrease in cash | — | — | — | — | — | — | 2,020† | (2,102)† |
| Net increase (decrease) in cash | 8,751 | 10,612† | (903)† | 3,700† | (769) | (997)† | 2,020† | (2,102)† |
| Cash — beginning of the period | 13,699 | 3,087 | 3,990 | 290 | 1,059 | 2,056 | 36 | 2,138 |
| Cash — end of the period | 22,450 | 13,699 | 3,087 | 3,990 | 290 | 1,059 | 2,056 | 36 |
| SUPPLEMENTAL CASH FLOW INFORMATION | ||||||||
| Cash paid for interest | 23 | 64† | 60† | 90† | 0 | 5† | 1† | 0† |
| Cash paid for taxes | — | — | 0† | — | — | — | 0† | — |
| SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||||||||
| Issuance of Series E preferred stock in connection with LOC | — | — | — | — | — | — | — | 5,593† |
| Issuance of Series E preferred stock in connection with line of credit | — | — | — | — | 0 | — | — | (3,900)† |
| Cumulative dividends on Series A preferred stock | — | 0† | 0† | — | — | 0† | 0† | — |
| Cumulative dividends on Series B preferred stock | — | 0† | 0† | — | — | 0† | 0† | — |
| Cumulative dividends on Series C preferred stock | — | 0† | 0† | — | — | 0† | 0† | — |
| Series F Preferred Stock | — | 0† | 0† | — | — | 0† | 0† | — |
| Series F-1 Preferred Stock Converted To Common Stock | — | 0† | 0† | — | — | 0† | 0† | — |
| Series F-2 Preferred Stock Converted To Common Stock | — | 0† | 0† | — | — | 0† | 0† | — |
| Preferred Stock Series A, B and C | — | 797† | 0† | — | — | 0† | 0† | — |
| Series F-1, F-2 and F-3 Preferred Stock | — | 0† | 0† | — | — | 0† | 0† | — |
| Net impact of reclassification of common stock to APIC in connection with reverse stock split | — | — | 3† | — | — | — | 0† | — |
| Issuance of Series E preferred stock in connection with line of credit | — | — | 0† | — | — | — | (5,593)† | — |
| Issuance of Series E preferred stock in connection with line of credit | — | — | — | — | — | 0† | — | — |
| Issuance of common stock in connection with equity line of credit | — | 0† | — | — | — | 0† | — | — |
| Issuance of Series F preferred stock in connection with exchange of Series D preferred stock | — | — | — | — | — | 0† | — | — |
| Issuance of Series F preferred stock in connection with exchange of Series D preferred stock | — | 0† | 0† | — | — | 0† | 0† | — |
| Issuance of common stock in connection with conversion of notes | — | 0† | 0† | 0† | 0 | (516)† | 2,165† | 0† |
| Commitment to issue shares of common stock in connection with March Waiver agreement | — | — | — | — | 0 | — | — | — |
| Deemed dividend for repricing of series D preferred stock | — | — | — | — | 0 | — | — | — |
| Issuance of common stock in connection with Senior Secured Notes settlement | — | 0† | — | — | — | 0† | — | — |
| Conversion of Senior Secured Notes into Series F preferred stock in connection with Exchange Agreements | — | 0† | — | — | — | 0† | — | — |
| Acquisitions of property and equipment included in liabilities | — | — | — | — | — | 429† | (69)† | (64)† |
| Purchase of property and equipment included in accounts payable | — | — | 540† | 0† | 0 | — | (69)† | (64)† |
| Commitment to issue shares of common stock in connection with Demand Notes | — | 0† | 0† | — | — | 0† | 0† | — |
| Right-of-use assets in exchange of operating lease liabilities | 84 | 0† | 0† | 560† | — | 1,168† | 0† | — |
| Reduction of right-of-use assets and lease liability due to termination | — | 0† | — | — | — | 51† | — | — |
| Acquisitions of property and equipment included in liabilities | 21 | — | — | — | — | — | — | — |
| Property and equipment acquired through notes payable | — | 585† | — | — | — | 0† | — | — |
| Prepaid property and equipment received | 750 | — | — | — | — | — | — | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.